These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 26269361)

  • 21. Variations in Peripherally Inserted Central Catheter Use and Outcomes in Michigan Hospitals.
    Chopra V; Smith S; Swaminathan L; Boldenow T; Kaatz S; Bernstein SJ; Flanders SA
    JAMA Intern Med; 2016 Apr; 176(4):548-51. PubMed ID: 26881938
    [No Abstract]   [Full Text] [Related]  

  • 22. Exogenous hormones, the risk of venous thromboembolism, and activated protein C resistance.
    Mueck AO
    Menopause; 2010; 17(6):1099-103. PubMed ID: 20975607
    [No Abstract]   [Full Text] [Related]  

  • 23. Oral contraceptive switching patterns in the United Kingdom: an important potential confounding variable in studies of venous thromboembolism.
    Farmer RD; Lawrenson RA; Hambleton IR
    Eur J Contracept Reprod Health Care; 1996; 1(1):31-7. PubMed ID: 9678135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of venous thromboembolism with drospirenone in combined oral contraceptive products.
    Sehovic N; Smith KP
    Ann Pharmacother; 2010 May; 44(5):898-903. PubMed ID: 20371756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-androgen contraceptive pills and higher risk of venous thromboembolism.
    Braithwaite I; Shirtcliffe P; Weatherall M; Beasley R
    N Z Med J; 2016 Feb; 129(1430):102-4. PubMed ID: 26914430
    [No Abstract]   [Full Text] [Related]  

  • 26. [Cardiovascular risks of combined oral contraceptives - beyond the French controversy].
    Gronier H; Robin G
    Gynecol Obstet Fertil; 2014 Mar; 42(3):174-81. PubMed ID: 24582295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thromboembolism as the adverse event of combined oral contraceptives in Japan.
    Sugiura K; Kobayashi T; Ojima T
    Thromb Res; 2015 Dec; 136(6):1110-5. PubMed ID: 26475406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drospirenone and VTE.
    Leppée M; Eric M; Culig J
    J Fam Plann Reprod Health Care; 2010 Jan; 36(1):44. PubMed ID: 20067674
    [No Abstract]   [Full Text] [Related]  

  • 29. The newer contraceptive pills and venous thromboembolism risk.
    Foran TM
    Med J Aust; 2014 Apr; 200(7):376-7. PubMed ID: 24794658
    [No Abstract]   [Full Text] [Related]  

  • 30. [Oral contraceptive pill and thrombotic risk: epidemiological studies].
    Fruzzetti F; Perini D; Spirito N; Manca R
    Minerva Ginecol; 2012 Dec; 64(6):539-49. PubMed ID: 23232538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined hormonal contraceptives and venous thromboembolism: putting the risks into perspective.
    Raymond EG; Burke AE; Espey E
    Obstet Gynecol; 2012 May; 119(5):1039-44. PubMed ID: 22525916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Introducing a specialist drug kardex can significantly change prescribing practices for VTE in cancer patients.
    Coleman N; Young R; Greally M; O'Riordan L; Breathnach O; Grogan L
    Ir Med J; 2014 Jun; 107(6):188. PubMed ID: 24988843
    [No Abstract]   [Full Text] [Related]  

  • 33. Comment on 'Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism'.
    Terplan M; Zuckerman D
    J Fam Plann Reprod Health Care; 2013 Oct; 39(4):304. PubMed ID: 24062505
    [No Abstract]   [Full Text] [Related]  

  • 34. Hormonal contraceptives and venous thromboembolism: an epidemiological update.
    Plu-Bureau G; Maitrot-Mantelet L; Hugon-Rodin J; Canonico M
    Best Pract Res Clin Endocrinol Metab; 2013 Feb; 27(1):25-34. PubMed ID: 23384743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The risk of deep venous thrombosis with oral contraceptives containing drospirenone.
    Dunn N
    BMJ; 2011 Apr; 342():d2519. PubMed ID: 21511807
    [No Abstract]   [Full Text] [Related]  

  • 36. Practice Patterns for Prophylaxis and Treatment of Venous Thromboembolism in German Cancer Patients.
    Matzdorff A; Ledig B; Stuecker M; Riess H
    Oncol Res Treat; 2016; 39(4):194-201. PubMed ID: 27160305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Venous thromboembolism prophylaxis in plastic surgery: a survey of the practice in Denmark.
    Nielsen LJ; Matzen SH
    J Plast Surg Hand Surg; 2017 Apr; 51(2):122-128. PubMed ID: 27310150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of venous thromboembolism among users of oral contraceptives: a review of two recently published studies.
    Shapiro S; Dinger J
    J Fam Plann Reprod Health Care; 2010 Jan; 36(1):33-8. PubMed ID: 20067670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular and general safety of a 24-day regimen of drospirenone-containing combined oral contraceptives: final results from the International Active Surveillance Study of Women Taking Oral Contraceptives.
    Dinger J; Bardenheuer K; Heinemann K
    Contraception; 2014 Apr; 89(4):253-63. PubMed ID: 24576793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism.
    Bitzer J; Amy JJ; Beerthuizen R; Birkhäuser M; Bombas T; Creinin M; Darney PD; Vicente LF; Gemzell-Danielsson K; Imthurn B; Jensen JT; Kaunitz AM; Kubba A; Lech MM; Mansour D; Merki G; Rabe T; Sedlecki K; Serfaty D; Seydoux J; Shulman LP; Sitruk-Ware R; Skouby SO; Szarewski A; Trussell J; Westhoff C
    Eur J Contracept Reprod Health Care; 2013 Jun; 18(3):143-7. PubMed ID: 23578274
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.